Merck's CEO Rob Davis emphasizes DEI as a strategic imperative, aligning it with scientific rigor and innovation, showcasing ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

The opening session sets the context and intent for the Inaugural Summit: USA-Saudi Biotech Alliance, outlining the strategic ...

Investors in biotech companies approach their investments with the mindset of praying or scratching a lottery ticket, as the success rate of new drug development is extremely low and the costs are ...

Academic systems once lagged in innovation but now accelerate AI adoption, making it a core pillar alongside education, research and clinical care.

Focusing on 2026 as a starting point, PwC has laid out several “strategic imperatives” pharma companies ought to pursue this ...

It’s been a subdued—albeit sunny—start to healthcare’s biggest conference in San Francisco. | It’s been a subdued—albeit ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--Weave Bio, an AI-native life sciences platform company, today announced that its AutoIND solution has received the “BioTech AI Innovation of the Year” award in the ...

We all know someone waiting on a medical breakthrough. It could be a parent battling a chronic illness, a colleague pushing ...

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...

This session highlights the role of the King Abdullah International Medical Research Center (KAIMRC) as a core enabling ...

Shares of Moderna (MRNA) have surged sharply this week, drawing renewed attention to exchange traded funds with significant ...